Fact CheckerSign in

NCT06984822Recruiting

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

Evaluation of Serum and Ocular Coherence Tomography Biomarkers in Patients With Diabetic Macular Edema Treated With Anti-VEGF or Dexamethasone Implant

Source: ClinicalTrials.gov · Last updated 21 Nov 2025

Brief summary (registry, in English)

This study aims to investigate the association between serum biomarkers and clinical response to anti-VEGF or dexamethasone implant by assessing OCT-biomarkers in patients with diabetic macular edema, DME, and to compare these with a group of naive patients (those not previously treated for DME).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
5 May 2025
Start date
1 Aug 2025
Primary completion date
31 Dec 2028
Lead sponsor
Vastra Gotaland Region
NCT number
NCT06984822

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 1 Aug 2025 to the primary completion date, 31 Dec 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of any other macular disease.
  • Previous treatment with dexamethasone implants in the last six months for those in the anti-VEGF group.
  • Previous treatment with anti-VEGF in the last two months for those in the dexamethasone implant group.
  • Prior vitreoretinal surgery.
  • Previous laser treatment of the macula.
  • Previous panretinal photocoagulation.
  • Ocular surgery in the previous 3 months.

Who the study is looking for

  • Type I or type II DM.
  • DME involving the center of the fovea with CFT more than 280 microns and the presence of intraretinal cysts.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ögonmottagning Mölndal/SU
Coordinator of this site? Confirm its status
MölndalSwedenNot yet recruiting
Sahlgrenska University Hospital, Department of Ophthalmology
Coordinator of this site? Confirm its status
MölndalSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.